Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and paromomycin

phosphatidylcholines has been researched along with paromomycin in 3 studies

Compound Research Comparison

Studies
(phosphatidylcholines)		Trials
(phosphatidylcholines)		Recent Studies (post-2010)
(phosphatidylcholines)		Studies
(paromomycin)		Trials
(paromomycin)		Recent Studies (post-2010) (paromomycin)
32,2044435,5931,42290292

Protein Interaction Comparison

ProteinTaxonomyphosphatidylcholines (IC50)paromomycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.0355
30S ribosomal protein S7Escherichia coli K-120.0355
50S ribosomal protein L15Escherichia coli K-120.0355
50S ribosomal protein L10Escherichia coli K-120.0355
50S ribosomal protein L11Escherichia coli K-120.0355
50S ribosomal protein L7/L12Escherichia coli K-120.0355
50S ribosomal protein L19Escherichia coli K-120.0355
50S ribosomal protein L1Escherichia coli K-120.0355
50S ribosomal protein L20Escherichia coli K-120.0355
50S ribosomal protein L27Escherichia coli K-120.0355
50S ribosomal protein L28Escherichia coli K-120.0355
50S ribosomal protein L29Escherichia coli K-120.0355
50S ribosomal protein L31Escherichia coli K-120.0355
50S ribosomal protein L31 type BEscherichia coli K-120.0355
50S ribosomal protein L32Escherichia coli K-120.0355
50S ribosomal protein L33Escherichia coli K-120.0355
50S ribosomal protein L34Escherichia coli K-120.0355
50S ribosomal protein L35Escherichia coli K-120.0355
50S ribosomal protein L36Escherichia coli K-120.0355
30S ribosomal protein S10Escherichia coli K-120.0355
30S ribosomal protein S11Escherichia coli K-120.0355
30S ribosomal protein S12Escherichia coli K-120.0355
30S ribosomal protein S13Escherichia coli K-120.0355
30S ribosomal protein S16Escherichia coli K-120.0355
30S ribosomal protein S18Escherichia coli K-120.0355
30S ribosomal protein S19Escherichia coli K-120.0355
30S ribosomal protein S20Escherichia coli K-120.0355
30S ribosomal protein S2Escherichia coli K-120.0355
30S ribosomal protein S3Escherichia coli K-120.0355
30S ribosomal protein S4Escherichia coli K-120.0355
30S ribosomal protein S5Escherichia coli K-120.0355
30S ribosomal protein S8Escherichia coli K-120.0355
30S ribosomal protein S9Escherichia coli K-120.0355
50S ribosomal protein L13Escherichia coli K-120.0355
50S ribosomal protein L14Escherichia coli K-120.0355
50S ribosomal protein L16Escherichia coli K-120.0355
50S ribosomal protein L23Escherichia coli K-120.0355
30S ribosomal protein S15Escherichia coli K-120.0355
50S ribosomal protein L17Escherichia coli K-120.0355
50S ribosomal protein L21Escherichia coli K-120.0355
50S ribosomal protein L30Escherichia coli K-120.0355
50S ribosomal protein L6Escherichia coli K-120.0355
30S ribosomal protein S14Escherichia coli K-120.0355
30S ribosomal protein S17Escherichia coli K-120.0355
30S ribosomal protein S1Escherichia coli K-120.0355
50S ribosomal protein L18Escherichia coli K-120.0355
50S ribosomal protein L2Escherichia coli K-120.0355
50S ribosomal protein L3Escherichia coli K-120.0355
50S ribosomal protein L24Escherichia coli K-120.0355
50S ribosomal protein L4Escherichia coli K-120.0355
50S ribosomal protein L22Escherichia coli K-120.0355
50S ribosomal protein L5Escherichia coli K-120.0355
30S ribosomal protein S21Escherichia coli K-120.0355
50S ribosomal protein L25Escherichia coli K-120.0355
50S ribosomal protein L36 2Escherichia coli K-120.0355

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murray, HW1
Carneiro, G; Fernandes, AP; Ferreira, LA; Ferreira, LS; Nunan, EA; Oliveira, MC; Ramaldes, GA; Santos, DC1
Ali, N; Banerjee, A; De, M1

Reviews

1 review(s) available for phosphatidylcholines and paromomycin

ArticleYear
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
    Expert review of anti-infective therapy, 2004, Volume: 2, Issue:2

    Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic

2004

Other Studies

2 other study(ies) available for phosphatidylcholines and paromomycin

ArticleYear
Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis.
    Journal of liposome research, 2010, Volume: 20, Issue:1

    Topics: Administration, Topical; Animals; Cholesterol; Female; Leishmaniasis, Cutaneous; Liposomes; Mice; Mice, Inbred BALB C; Paromomycin; Particle Size; Phosphatidylcholines; Skin

2010
Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Amines; Animals; Anti-Bacterial Agents; Cells, Cultured; Cricetinae; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunity, Humoral; Immunologic Factors; Interleukin-10; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Paromomycin; Phosphatidylcholines; Transforming Growth Factor beta

2011